Katherine Kunz
Family · Orange City, FLNPI 1538973920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations.
Across 98 payments — averaging $24.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$271
- AstraZeneca$235
- Novartis$164
- Incyte Corporation$161
- Johnson & Johnson$147
- Eisai Inc.$110
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,20793%
- Education$1787%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 12 | $271 |
| AstraZeneca(2 entities) | 9 | $235 |
| Novartis | 8 | $164 |
| Incyte Corporation | 6 | $161 |
| Johnson & Johnson | 8 | $147 |
| Eisai Inc. | 5 | $110 |
| Sanofi US Services Inc. | 1 | $104 |
| Ipsen Biopharmaceuticals, Inc | 1 | $100 |
| GSK | 4 | $81 |
| Dendreon Pharmaceuticals LLC | 3 | $76 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Sanofi | 3 | $65 |
| Fennec Pharmaceuticals, Inc. | 3 | $62 |
| Springworks Therapeutics, Inc. | 1 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Tersera Therapeutics LLC | 2 | $53 |
| EMD Serono, Inc. | 2 | $51 |
| Novocure Inc. | 2 | $43 |
| Bristol Myers Squibb | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| Agios Pharmaceuticals, Inc. | 1 | $31 |
| Geron Corporation | 2 | $31 |
| Servier Pharmaceuticals LLC | 2 | $31 |
| Boehringer Ingelheim | 1 | $30 |
| Bayer | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Beone Medicines USA, Inc. | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Pfizer | 1 | $23 |
| Legend Biotech USA Inc. | 1 | $23 |
| Syndax Pharmaceuticals, Inc. | 1 | $23 |
| Pharmaessentia USA Corporation | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Array Biopharma Inc | 1 | $20 |
| Gilead | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$2,385 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Other family in Orange City
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.